Acute lymphoblastic leukemia with Burkitt-like morphologic features and high myeloperoxidase activity

American Journal of Clinical Pathology

Volumn 132, Issue 2, 2009, Pages 182-185

  Rytting, Michael E ^a   Kantarjian, Hagop ^a   Albitar, Maher ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

Acute lymphoblastic leukemia; Burkitt; Mixed lineage; Myeloperoxidase; Therapy

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; IDARUBICIN; LYMPHOCYTE MEMBRANE IMMUNOGLOBULIN; MITOXANTRONE; MYELOPEROXIDASE; TOPOTECAN; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER REGRESSION; CELL VACUOLE; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CYTOPLASM; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; LYMPHOBLAST; LYMPHOCYTE STRUCTURE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FLOW CYTOMETRY; HUMANS; MIDDLE AGED; PEROXIDASE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 68549090941     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPZ7E9IMXVSNPT     Document Type: Article

References (10)

1. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of the acute leukemias: a report of the French-American- British Cooperative Group. Ann Intern Med. 1985;103:620-625.
2. Jaffe E, Harris N, Stein H, et al, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001. World Health Organization Classification of Tumours.
3. Wright S, Chucrallah A, Chong YY, et al. Acute lymphoblastic leukemia with myeloperoxidase activity. Am J Hematol. 1996;51:147-151.
4. Serrano J, Roman J, Jimenez A, et al. Genetic, phenotypic and clinical features of acute lymphoblastic leukemias expressing myeloperoxidase mRNA detected by RT-PCR. Leukemia. 1990;13:175-180.
5. Serrano J, Lo Coco F, Sprovieri T, et al. Myeloperoxidase gene expression in non-infant pro-B acute lymphoblastic leukemia with or without ALL1/AF4 transcript. Br J Haematol. 2000;111:1065-1070.
6. Austin G, Alvarado M, Autin E, et al. Prevalence of myeloperoxidase gene expression in infant acute lymphocytic leukemia. Am J Clin Pathol. 1998;110:575-581.
7. Crisan D, Topalovski M, O'Malley B. Myeloperoxidase mRNA analysis in acute lymphoblastic leukemia. Diagn Mol Pathol. 1996;5:236-248.
8. Kantarjian H, Thomas D, O'Brien S, et al. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer. 2004;101:2788-2801.
9. Lai R, Hirsch-Ginsberg CF, Bueso-Ramos C. Pathologic diagnosis of acute lymphocytic leukemia. Hematol Clin North Am. 2000;14:1209-1235.
10. Kantarjian H, Hirsch-Ginsburg C, Yee G, et al. Mixedlineage leukemia revisited: acute lymphocytic leukemia with myeloperoxidase-positive blasts by electron microscopy. Blood. 1990;76:808-813.